Modeling grade progression in an active surveillance study

Lurdes Y T Inoue, Bruce J. Trock, Alan W. Partin, Herbert B. Carter, Ruth Etzioni

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Prostate cancer grade, assessed with the Gleason score, describes how abnormal the tumor tissue and cells appear, and it is an important prognostic indicator of disease progression. Whether prostate tumors change grade is a question that has implications for screening and treatment. Empirical data on tumor grade over time have become available from men biopsied regularly as part of active surveillance (AS). However, biopsy (BX) grade is subject to misclassification. In this article, we develop a model that allows for estimation of the time of grade change while accounting for the misclassification error from BX grade. We use misclassification rates from studies of prostate cancer BXs followed by radical prostatectomy. Estimation of the transition times from true low-grade to high-grade disease is conducted within a Bayesian framework. We apply our model to serial observations on BX grade among 627 cases enrolled in a cohort of AS patients at Johns Hopkins University who were biopsied annually and referred to treatment if there was any evidence of disease progression on BX. We consider different prior distributions for the time to true grade progression. The estimated likelihood of grade progression within 10years of study entry ranges from 12% to 24% depending on the prior. We conclude that knowledge of rates of grade misclassification allows for determination of true grade progression rates among men with serial BXs on AS. Although our results are sensitive to prior specifications, they indicate that in a nontrivial fraction of the patient population, tumor grade can progress.

Original languageEnglish (US)
Pages (from-to)930-939
Number of pages10
JournalStatistics in Medicine
Volume33
Issue number6
DOIs
StatePublished - Mar 15 2014
Externally publishedYes

Fingerprint

Progression
Surveillance
Tumor
Modeling
Prostate Cancer
Misclassification
Disease Progression
Neoplasms
Prostatic Neoplasms
Neoplasm Grading
Misclassification Rate
Misclassification Error
Prostatectomy
Prostate
Prior distribution
Screening
Likelihood
Biopsy
Specification
Therapeutics

Keywords

  • Bayesian analysis
  • Prostate cancer
  • Simulation modeling

ASJC Scopus subject areas

  • Epidemiology
  • Statistics and Probability

Cite this

Inoue, L. Y. T., Trock, B. J., Partin, A. W., Carter, H. B., & Etzioni, R. (2014). Modeling grade progression in an active surveillance study. Statistics in Medicine, 33(6), 930-939. https://doi.org/10.1002/sim.6003

Modeling grade progression in an active surveillance study. / Inoue, Lurdes Y T; Trock, Bruce J.; Partin, Alan W.; Carter, Herbert B.; Etzioni, Ruth.

In: Statistics in Medicine, Vol. 33, No. 6, 15.03.2014, p. 930-939.

Research output: Contribution to journalArticle

Inoue, LYT, Trock, BJ, Partin, AW, Carter, HB & Etzioni, R 2014, 'Modeling grade progression in an active surveillance study', Statistics in Medicine, vol. 33, no. 6, pp. 930-939. https://doi.org/10.1002/sim.6003
Inoue LYT, Trock BJ, Partin AW, Carter HB, Etzioni R. Modeling grade progression in an active surveillance study. Statistics in Medicine. 2014 Mar 15;33(6):930-939. https://doi.org/10.1002/sim.6003
Inoue, Lurdes Y T ; Trock, Bruce J. ; Partin, Alan W. ; Carter, Herbert B. ; Etzioni, Ruth. / Modeling grade progression in an active surveillance study. In: Statistics in Medicine. 2014 ; Vol. 33, No. 6. pp. 930-939.
@article{260ee544b90d4f2693c2505fd7dc6e56,
title = "Modeling grade progression in an active surveillance study",
abstract = "Prostate cancer grade, assessed with the Gleason score, describes how abnormal the tumor tissue and cells appear, and it is an important prognostic indicator of disease progression. Whether prostate tumors change grade is a question that has implications for screening and treatment. Empirical data on tumor grade over time have become available from men biopsied regularly as part of active surveillance (AS). However, biopsy (BX) grade is subject to misclassification. In this article, we develop a model that allows for estimation of the time of grade change while accounting for the misclassification error from BX grade. We use misclassification rates from studies of prostate cancer BXs followed by radical prostatectomy. Estimation of the transition times from true low-grade to high-grade disease is conducted within a Bayesian framework. We apply our model to serial observations on BX grade among 627 cases enrolled in a cohort of AS patients at Johns Hopkins University who were biopsied annually and referred to treatment if there was any evidence of disease progression on BX. We consider different prior distributions for the time to true grade progression. The estimated likelihood of grade progression within 10years of study entry ranges from 12{\%} to 24{\%} depending on the prior. We conclude that knowledge of rates of grade misclassification allows for determination of true grade progression rates among men with serial BXs on AS. Although our results are sensitive to prior specifications, they indicate that in a nontrivial fraction of the patient population, tumor grade can progress.",
keywords = "Bayesian analysis, Prostate cancer, Simulation modeling",
author = "Inoue, {Lurdes Y T} and Trock, {Bruce J.} and Partin, {Alan W.} and Carter, {Herbert B.} and Ruth Etzioni",
year = "2014",
month = "3",
day = "15",
doi = "10.1002/sim.6003",
language = "English (US)",
volume = "33",
pages = "930--939",
journal = "Statistics in Medicine",
issn = "0277-6715",
publisher = "John Wiley and Sons Ltd",
number = "6",

}

TY - JOUR

T1 - Modeling grade progression in an active surveillance study

AU - Inoue, Lurdes Y T

AU - Trock, Bruce J.

AU - Partin, Alan W.

AU - Carter, Herbert B.

AU - Etzioni, Ruth

PY - 2014/3/15

Y1 - 2014/3/15

N2 - Prostate cancer grade, assessed with the Gleason score, describes how abnormal the tumor tissue and cells appear, and it is an important prognostic indicator of disease progression. Whether prostate tumors change grade is a question that has implications for screening and treatment. Empirical data on tumor grade over time have become available from men biopsied regularly as part of active surveillance (AS). However, biopsy (BX) grade is subject to misclassification. In this article, we develop a model that allows for estimation of the time of grade change while accounting for the misclassification error from BX grade. We use misclassification rates from studies of prostate cancer BXs followed by radical prostatectomy. Estimation of the transition times from true low-grade to high-grade disease is conducted within a Bayesian framework. We apply our model to serial observations on BX grade among 627 cases enrolled in a cohort of AS patients at Johns Hopkins University who were biopsied annually and referred to treatment if there was any evidence of disease progression on BX. We consider different prior distributions for the time to true grade progression. The estimated likelihood of grade progression within 10years of study entry ranges from 12% to 24% depending on the prior. We conclude that knowledge of rates of grade misclassification allows for determination of true grade progression rates among men with serial BXs on AS. Although our results are sensitive to prior specifications, they indicate that in a nontrivial fraction of the patient population, tumor grade can progress.

AB - Prostate cancer grade, assessed with the Gleason score, describes how abnormal the tumor tissue and cells appear, and it is an important prognostic indicator of disease progression. Whether prostate tumors change grade is a question that has implications for screening and treatment. Empirical data on tumor grade over time have become available from men biopsied regularly as part of active surveillance (AS). However, biopsy (BX) grade is subject to misclassification. In this article, we develop a model that allows for estimation of the time of grade change while accounting for the misclassification error from BX grade. We use misclassification rates from studies of prostate cancer BXs followed by radical prostatectomy. Estimation of the transition times from true low-grade to high-grade disease is conducted within a Bayesian framework. We apply our model to serial observations on BX grade among 627 cases enrolled in a cohort of AS patients at Johns Hopkins University who were biopsied annually and referred to treatment if there was any evidence of disease progression on BX. We consider different prior distributions for the time to true grade progression. The estimated likelihood of grade progression within 10years of study entry ranges from 12% to 24% depending on the prior. We conclude that knowledge of rates of grade misclassification allows for determination of true grade progression rates among men with serial BXs on AS. Although our results are sensitive to prior specifications, they indicate that in a nontrivial fraction of the patient population, tumor grade can progress.

KW - Bayesian analysis

KW - Prostate cancer

KW - Simulation modeling

UR - http://www.scopus.com/inward/record.url?scp=84893781704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893781704&partnerID=8YFLogxK

U2 - 10.1002/sim.6003

DO - 10.1002/sim.6003

M3 - Article

VL - 33

SP - 930

EP - 939

JO - Statistics in Medicine

JF - Statistics in Medicine

SN - 0277-6715

IS - 6

ER -